Cancer Nursing Bulletin, July-August-September 2023
Implementation and evaluation of remote medical monitoring in oncology at Gustave Roussy.
Dec 4, 2025
2 minutes
Citation
Cancer Nursing Bulletin. 2023;23(3):126-129. doi:10.1684/bic.2023.251
Authors
Juliette Fanton d’Andon 1, ArianeCocq 1, Mélanie Gourhant 1, Pierre Morichau Beauchant 1, Dr ArlindoFerreira 1, Dr Martina Pagliuca 2, Dr Florian Scotté 2, Dr Mario Di Palma 2, Me Abbas Maya 2, Dr Inès Vas Duarte Luis 2, Dr Barbara Pistilli 2, Dr Joana Ribeiro 2.
Affiliation
1. Resilience ;2. Institut Gustave Roussy.
Introduction
For many years, clinical studies have demonstrated the clinical and organizational benefits of Remote Patient Monitoring (RPM) [1,2]:
- Reduction in severe toxicities,
- Improvement in treatment tolerance and increase in treatment duration and relative dose intensity,
- Improvement in quality of life,
- Increase in overall survival for metastatic diseases,
- Reduction in unscheduled emergency room visits and hospitalizations,
- Improved care pathway coordination.
Remote Patient Monitoring represents a major advancement enabling better management of patients affected by cancer. It is initiated upon medical prescription. First-line patient monitoring is performed by the Coordinating Nurse (IDEC) (autonomous role under Article R. 4311-5 and upon prescription under Article R. 4311-7).
A study was conducted to:
- describe the RPM activity for patients treated for breast neoplasia at Gustave Roussy,
- identify the main symptoms reported by patients, thus providing a basis for reflection regarding their care management.
Sources
1. Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes symptom monitoring during routine cancer treatment. JAMA 2017 ; 318 : 197-8.
2. Mir O, Ferrua M, Fourcade A. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nature Medicine 2022 ; 28 : 1224-31.
